San Diego, United States
January Therapeutics is a pioneering biotechnology startup founded in 2016 with a vision to transform cancer treatment. Their mission is embedded in their slogan, "Transformational Oncology," which encapsulates the essence of their groundbreaking work.
The company is dedicated to developing next-generation targeted anti-cancer therapies by harnessing the potential of protein-based nano-formulations. These innovative formulations have demonstrated remarkable enhancements in the efficacy of existing drugs. January Therapeutics aims to leverage this scientific breakthrough by creating unique chemical matter that enhances established anti-cancer mechanisms while introducing new cancer-targeting properties.
They strive to develop novel drugs with superior efficacy and reduced toxicity, particularly focusing on addressing hard-to-treat malignancies such as advanced pancreatic, lung, and ovarian cancers.
Based in the United States, January Therapeutics recently secured a significant $1.20M investment in a Venture Round on 15th January 2019. This investment underscores the confidence of the investor community in the potential of January Therapeutics' innovative approach to revolutionize oncology.
With their commitment to advancing cancer treatment, January Therapeutics stands at the forefront of biotechnology and healthcare, poised to make a meaningful impact in the battle against cancer.
